RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
ULBI
Ultralife Corporation
There isn't enough reported data to score ULBI yet.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ULBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Weak |
ULBI's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
ULBI PE Valuation
ULBI has no meaningful PE right now: it lost money over the past year.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ULBI Forward outlook
There aren't enough analyst estimates for ULBI to show an outlook.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
ULBI Earnings Per Share
ULBI has the edge over RKLB in the latest year-over-year earnings comparison.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over ULBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
ULBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $48.3M | +11% |
| Q2 2026 | $47.9M | -1.3% |
| Q1 2026 | $47.4M | -6.5% |
| Q4 2025 | $48.5M | +11% |
| Q3 2025 | $43.4M | +22% |
| Q2 2025 | $48.6M | +13% |
| Q1 2025 | $50.7M | +21% |
| Q4 2024 | $43.9M | -1.6% |
ULBI's revenue has held roughly level: $48M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.6% | +8.8 points |
| Q2 2026 | 7.2% | +2.5 points |
| Q1 2026 | -0.5% | -7.2 points |
| Q4 2025 | -22% | -25 points |
| Q3 2025 | -2.2% | -3.6 points |
| Q2 2025 | 4.7% | -4.5 points |
| Q1 2025 | 6.7% | -3 points |
| Q4 2024 | 3.4% | -4.8 points |
ULBI has the edge over RKLB on profitability, with a higher operating margin.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has the edge over ULBI on cash flow, with more consistent year-over-year improvement.
ULBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.5M | -$2.7M |
| Q2 2026 | $735K | -85% |
| Q1 2026 | $1.5M | -40% |
| Q4 2025 | $607K | -75% |
| Q3 2025 | -$797K | -119% |
| Q2 2025 | $4.8M | -44% |
| Q1 2025 | $2.5M | +$2.9M |
| Q4 2024 | $2.4M | +71% |
ULBI's free cash flow was −$694,000 over the past year, against $9M the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ULBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -17K shares |
| 1 year | +0.3% | +51K shares |
| 3 years | +2.4% | +394K shares |
| 5 years | +2.7% | +437K shares |
| Available history | +3.2% | +518K shares |
ULBI has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q4 2019 | — |
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ULBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 38.3x | High |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 3.2x | Elevated |
| Q4 2024 | 3.4x | Elevated |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | 0.3x | Very low |
| Q1 2024 | 0.9x | Very low |
ULBI's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.4 years a year ago.
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
ULBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 82.9 | Overbought |
| Stochastic | 99.6 | Overbought |
ULBI's weekly RSI is 83 (overbought) and its Stochastic is 100 (overbought).
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
ULBI PE vs Industrials Sector
| Metric | ULBI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ULBI has no meaningful PE right now: it lost money over the past year.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
ULBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.76 | 62% above |
| 20 week MA | $7.54 | 109% above |
| 50 week MA | $6.82 | 131% above |
| 100 week MA | $6.76 | 133% above |
| 200 week MA | $7.29 | 116% above |
ULBI has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.
ULBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.29 | $6.36 | -13% |
| 2021 | $6.36 | $5.96 | -6.3% |
| 2022 | $5.96 | $3.89 | -35% |
| 2023 | $3.89 | $6.82 | +75% |
| 2024 | $6.82 | $7.29 | +6.9% |
| 2025 | $7.29 | $5.76 | -21% |
| 2026 YTD | $5.76 | $15.8 | +174% |
ULBI has the edge over RKLB on returns for 2026, with the stronger performance.